CAR T-cell therapy ‘holds great promise’ advanced chronic lymphocytic leukemia – Healio
|
CAR T-cell therapy 'holds great promise' advanced chronic lymphocytic leukemia
Healio NEW YORK — Chimeric antigen receptor T–cell therapy “holds great promise” for patients with advanced relapsed or refractory chronic lymphocytic leukemia, according to one of the program chairs of HemOnc Today New York. “There are new molecules and new … |
